Crossmark

Insilico design, ADMET screening, MM-GBSA binding free energy of novel 1,3,4 oxadiazoles linked Schiff bases as PARP-1 inhibitors targeting breast cancer

Crossref DOI link: https://doi.org/10.1186/s43094-021-00321-4

Published Online: 2021-08-28

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shridhar Deshpande, Narayan

Mahendra, Gowdru Srinivasa

Aggarwal, Natasha Naval

Gatphoh, Banylla Felicity Dkhar

Revanasiddappa, Bistuvalli Chandrashekharappa
License Information

Text and Data Mining valid from 2021-08-28

Version of Record valid from 2021-08-28
More Information

Article History

Received: 8 June 2021

Accepted: 13 August 2021

First Online: 28 August 2021

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no conflict of interests.

Document is current

Any future updates will be listed below